[[STAGE]] Concomitant radio-chemotherapy in esophageal cancer: definitive or neoadjuvant treatment in operable patients?

Concomitant radio-chemotherapy in esophageal cancer: definitive or neoadjuvant treatment in operable patients?

E-session 603001

Expert

Francesco Cellini

Fondazione Policlinico Universitario "A. Gemelli" IRCCS
Rome, Italy

Discussant

Berardino De Bari

Radiation Oncologist
Réseau Hospitalier Neuchâtelois
La Chaux-de-Fonds, Switzerland

This e-Session is part of the following pathway(s):

Feb 2022

ESCO is the College of the European School of Oncology for ESO students offering a structured educational pathway to enhance their oncology careers.

The e-ESO e-Sessions are part of the Master-Online Study Program Advanced Oncology of Ulm University
www.uni-ulm.de

Oncology education together via social media